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pressed on NK cells, NKT cells, CD8 T cells,  T cells,75743 Paris Cedex 15
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a transmembrane adaptor molecule, DAP10, which has
a YxxM motif that recruits the p85 phoshoinositide-3
(PI3) kinase subunit (Wu et al., 1999). Therefore, NKG2D-Summary
dependent activation utilizes the PI3 kinase pathway.
Recent studies revealed that cytotoxicity of mouse NKNonobese diabetic (NOD) mice, a model of insulin-
dependent diabetes mellitus, have a defect in natural cells against YAC-1 mainly depends on NKG2D (Jamie-
son et al., 2002).killer (NK) cell-mediated functions. Here we show im-
pairment in an activating receptor, NKG2D, in NOD NK Genomic linkage analysis in NOD mice has revealed
several insulin-dependent diabetes (Idd) loci (Wicker etcells. While resting NK cells from C57BL/6 and NOD
mice expressed equivalent levels of NKG2D, upon acti- al., 1995). Interestingly, gene(s) conferring susceptibility
to diabetes in NOD mice (Ghosh et al., 1993) has beenvation NOD NK cells but not C57BL/6 NK cells ex-
pressed NKG2D ligands, which resulted in downmodu- mapped to a region on chromosome 6 designated the
natural-killer-gene complex (NKC) that contains a clus-lation of the receptor. NKG2D-dependent cytotoxicity
and cytokine production were decreased because of ter of genes preferentially expressed by NK cells (Rogner
et al., 2001; Yokoyama and Seaman, 1993), includingreceptor modulation, accounting for the dysfunction.
Modulation of NKG2D was mostly dependent on the NKG2D (NKG2D is within the NKC [Ho et al., 1998]).
Thus, we examined NKG2D-dependent cytotoxicity andYxxM motif of DAP10, the NKG2D-associated adaptor
that activates phosphoinositide 3 kinase. These re- IFN- production in NOD mice and investigated whether
the underlying NK cell abnormalities of NOD mice maysults suggest that NK cells may be desensitized by
exposure to NKG2D ligands. involve the NKG2D-dependent activation pathway.
Introduction Results
Insulin-dependent diabetes mellitus (IDDM) is a multi- Impaired NKG2D-Dependent Cytotoxicity and IFN-
factorial autoimmune disease characterized by the de- Production in Activated NOD NK Cells
struction of insulin-producing  cells by autoreactive T In this study, we compared NKG2D-dependent immune
lymphocytes in the pancreas (Bach, 1994; Castano and responses using interleukin (IL)-2-activated NK cells
Eisenbarth, 1990). Accompanying T cell-dependent au- from NOD and NK1.1 congenic NOD (NK1.1 NOD) mice.
toimmune responses, IDDM patients, and nonobese dia- Because Nkrp1 (NK1.1) is linked closely with NKG2D,
betic (NOD) mice demonstrate impaired immune re- the NKG2D gene in the NK1.1 congenic NOD mice is
sponses against certain pathogens (Attallah et al., 1987; expected to be derived from the C57BL/6 strain (Car-
Cameron et al., 1998; Kataoka et al., 1983). In addition, naud et al., 2001). NK cell-mediated cytotoxicity against
several reports suggest that natural killer (NK) cell-medi- YAC-1 target cells is primarily dependent upon NKG2D-
ated functions may be abnormal in IDDM patients and dependent activation (Jamieson et al., 2002; our unpub-
NOD mice (Carnaud et al., 2001; Kataoka et al., 1983; lished data). Consistent with prior reports, cytotoxic ac-
Nair et al., 1986; Negishi et al., 1986; Poulton et al., tivity of NOD NK cells against YAC-1 was significantly
less than C57BL/6 NK cells (Figure 1A). Activated NK
cells from NK1.1-congenic NOD mice also demon-*Correspondence: lanier@itsa.ucsf.edu
4 These authors contributed equally to this work. strated less cytotoxicity against YAC-1 targets com-
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Figure 1. NKG2D-Dependent Cytotoxicity and IFN- Production by NK1.1 NOD and NOD NK Cells
(A) The cytotoxicity of C57BL/6, NK1.1 NOD, and NOD NK cells against YAC-1 target cells was blocked by anti-mouse NKG2D mAb. Purified
and IL-2-activated C57BL/6, NK1.1 NOD, and NOD NK cells were precultured with an anti-NKG2D mAb (rat IgG2a isotype) or an isotype-
control rat Ig for 30 min and then mixed with target cells. The anti-NKG2D mAb (squares) or the cIg (circles) was present throughout the
cytotoxic assay. Cytotoxicity was measured by 51Cr release after 4 hr. Lytic units (LU40) against YAC-1 targets were as follows: C57BL/6 (LU40 
1.17  106 ), NK1.1NOD (LU40  7.61 104 ), and NOD (LU40  6.47  104 ).
(B) NKG2D-dependent cytotoxicity mediated by NK1.1 NOD and NOD NK cells. NK cells were purified and activated with IL-2 as in Figure
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pared with the lytic activity of C57BL/6 NK cells. In addi- activated NK cells from NOD and NK1.1 NOD mice ex-
pressed ligands for NKG2D whereas NKG2D ligandstion, anti-NKG2D monoclonal antibody (a-NKG2D mAb)
efficiently inhibited cytotoxicity against YAC-1 by NK were undetectable on NK cells from C57BL/6 mice (Fig-
ure 2C). Moreover, the presence of RAE-1 in activatedcells from all strains of mice (Figure 1A). To directly
evaluate the function of NKG2D-mediated cytotoxicity, NOD NK cells but not C57BL/6 NK cells was confirmed
by analyzing RAE-1 mRNA expression using real-timewe analyzed the ability of activated C57BL/6 and NOD
NK cells to kill Ba/F3 pro-B cells transfected with a quantitative RT-PCR (Figure 2D). Transcripts of RAE-1,
, and  and H-60 were detected in NOD activated NKNKG2D ligand, RAE-1 (Cerwenka et al., 2000). Only low
levels of cytotoxicity were observed against BaF/3 mock cells. By contrast, transcripts for NKG2D ligands were
not present in NK cells from C57BL/6 mice (Figure 2D).transfectants using NK cells from all strains of mice.
In contrast, the NKG2D-dependent cytotoxicity against In addition, activated NK cells from NOD and NK1.1
NOD mice stained positively with a mouse NKG2D-IgRAE-1 transfectants was remarkably less using acti-
vated NK cells from NOD or NK1.1 NOD mice compared fusion protein, and this was confirmed using an anti-
RAE-1-specific mAb (Figure 2E). These results suggestwith C57BL/6 NK cells (Figure 1B). NKG2D-dependent
cytotoxicity of these NK cells was completely abrogated that ligand-dependent modulation of NKG2D may ac-
count for the impairment in NKG2D-dependent functionby a-NKG2D mAb (Figure 1B). Thus, these findings sug-
gest that a defect in the NKG2D-dependent activation in NOD NK cells.
pathway in NOD and NK1.1 NOD NK cells may be re-
sponsible for the diminished cytotoxicity against YAC-1 Ligand-Induced NKG2D Modulation
target cells. In addition, we found that NKG2D-depen- We investigated whether NKG2D is modulated by the
dent IFN- production, induced by crosslinking with interaction with its ligands. C57BL/6 NK cells were co-
anti-NKG2D mAb, was reduced using activated NK cells cultured with B16 melanoma cells transfected with
from NOD or NK1.1 NOD mice as compared with that RAE-1 or mock transfectants. Although no difference
produced by activated C57BL/6 NK cells (Figure 1C). was observed in CD44 expression, NKG2D expression
These results indicated that NKG2D-dependent func- on NK cells was dramatically decreased after coculture
tions are decreased in activated NK1.1 NOD and NOD with RAE-1-bearing transfectants as compared to NK
NK cells. cells cocultured with mock transfectants (Figure 3A) or
NK cells cultured in the absence of target cells (data
not shown). NK cells were harvested and assayed forNKG2D Expression on NOD NK Cells
To explain the abnormal NKG2D function in NOD NK cytolytic activity against YAC-1 targets. The diminished
levels of NKG2D on NK cells cocultured with RAE-1cells, we examined NKG2D expression on NK1.1 NOD,
NOD, and C57BL/6 NK cells. While low but comparable transfectants correlated with the impaired cytolytic ac-
tivity against YAC-1 (killing was 40% less than thatlevels of NKG2D were observed on fresh NK cells from
these strains (data not shown), NKG2D expression was with NK cells cocultured with mock transfectants) (Fig-
ure 3B). Similar results were obtained using RAE-1 trans-dramatically decreased in activated NK cells from NOD
and NK1.1 NOD mice as compared to C57BL/6 NK cells fected cells as targets in cytotoxicity assays (Figure 3C).
In addition, NKG2D-dependent IFN- production was(Figure 2A). The decrease in NKG2D expression on NOD
NK cells was selective since the expression levels of decreased substantially in NK cells previously cocul-
tured with RAE-1 transfectants as compared with NKCD44 and NK1.1 were equivalent to C57BL/6 NK cells
(Figure 2A). To determine whether the decrease in cells cocultured with mock transfectants (Figure 3D).
To examine whether NKG2D is also modulated on NKNKG2D surface expression was caused by transcrip-
tional regulation, we measured mRNA expression of cells in vivo, we injected RAE-1 transfected RMA cells
or mock-transfected RMA cells into the spleen ofNKG2D and DAP10 in NK cells by real-time quantitative
PCR. Prior studies have shown that expression of C57BL/6 mice. After 5 days, splenocytes were harvested
and analyzed by flow cytometry. Although no differenceNKG2D on the cell surface requires its association with
DAP10 (Wu et al., 1999). As shown in Figure 2B, NOD was observed in NK1.1 (data not shown) or CD44 ex-
pression on NK cells from mice injected with RAE-1NK cells expressed equivalent of NKG2D and DAP10
mRNA compared to C57BL/6 NK cells, excluding differ- RMA cells or mock RMA cells, the levels of NKG2D were
substantially reduced on NK cells from mice injectedential transcription as the cause for diminished NKG2D
expression on NOD NK cells. with RAE-1 RMA transfectants (Figure 3E). Further-
more, we investigated whether NKG2D modulation wasAn alternative possibility that may account for the
difference between NKG2D expression on NOD versus reversible. NK cells were cocultured with irradiated
RAE-1 B16 or mock-transfected B16 cells, and ligand-C57BL/6 NK cells was ligand-induced modulation of
NKG2D in NOD NK cells. Unexpectedly, we found that induced modulation of NKG2D was confirmed. NK cells
1A. Cytotoxic activity against RAE-1 transfected Ba/F3 cells and mock Ba/F3 transfectants was tested using a 4 hr 51Cr release assay. Data
are represented as the mean % cytotoxicity 	 SD (triplicates). Similar results were obtained in two independent experiments.
(C) NKG2D-dependent IFN- production by NK1.1 NOD and NOD NK cells. NK cells were stimulated with immobilized mAb (1 
g ml1) or IL-
12 (1 ng ml1) for 18 hr. Conditions were as follows: anti-NKG2D mAb (filled column), rat cIg (open column), anti-NK1.1 mAb (hatched column),
and IL-12 (gray column). Culture supernatants were collected for the measurement of IFN- by ELISA. Differences in IFN- production of NK
cells from C57BL/6, NOD, and NK1.1 NOD induced by anti-NKG2D mAb stimulation were highly significant. p  0.01, C57BL/6 versus NK1.1
NOD; p  0.01, C57BL/6 versus NOD.
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Figure 2. NKG2D Expression on NOD NK Cells
(A) NKG2D expression was modulated on NK1.1NOD and NOD NK cells. Purified NK cells prepared from C57BL/6, NK1.1NOD, and NOD mice
were cultured with IL-2 for 4 days. These NK cells were stained with biotinylated anti-NKG2D mAb, biotinylated isotype control Ig (cIg), PE-
conjugated anti-CD44 mAb, and PE-conjugated anti-NK1.1 mAb. To detect NKG2D expression, PE-conjugated streptavidin was used as the
second step reagent. In the upper panel, the dotted line shows isotype cIg staining, and the thick line shows NKG2D expression on NK cells.
Similar results were observed when an H-60 Ig Fc fusion protein was used to detect NKG2D (data not shown). The dotted lines show isotype
cIg staining (middle and lower panels). The thick line represents CD44 (middle panel) or NK1.1 (lower panel) expression on these NK cells.
(B) NKG2D and DAP10 transcripts in C57BL/6, NK1.1 NOD, and NOD NK cells quantitated by real-time PCR. Total RNA was prepared from
purified and IL-2-activated NK cells from C57BL/6, NK1.1NOD, and NOD mice. Real-time PCR was performed as described in the Experimental
Procedures. Data were normalized by the amount of HPRT mRNA. Data are shown as the mean cycles of normalized NKG2D or DAP10
expression 	 SD (triplicates).
(C) NKG2D ligands were expressed on NK1.1 NOD and NOD NK cells. NK cells were prepared as in (A). NK cells were stained with a mouse
NKG2D-human Ig Fc fusion protein (NKG2D Ig) or control human Ig (cIg). To detect the binding of NKG2D-Ig, a PE-conjugated anti-human
IgG antibody (anti-human Ig PE) was used as a second step antibody. The dotted line represents control human Ig staining on NK cells. The
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were harvested and purified to remove residual tumor downmodulation, we treated NKG2D-DAP10 transfec-
tants cocultured with RAE-1 transfectants with the lyso-cells and then cultured in IL-2 only for 24 hr. In the
absence of ligand, expression of NKG2D was restored to some inhibitors, NH4Cl, or chloroquine. In the Ba/F3
transfectants, NKG2D modulation was not influencednormal levels (Figure 3F). Therefore, NKG2D modulation
was reversible. These results indicate that NKG2D mod- by the lysosome inhibitors (Figure 4C), suggesting that
NKG2D downmodulation was independent of the lyso-ulation is caused by the interaction with NKG2D ligands,
which in turn leads to a decrease in NKG2D-dependent somal compartment. Endocytosis can be mediated
by either clathrin-dependent or clathrin-independentcytotoxicity and IFN- production.
mechanisms. Because clathrin-dependent endocytosis
is inhibited by hypertonic conditions (Cefai et al., 1998;DAP10-Mediated PI3 Kinase Activation Augments
Rapoport et al., 1997; Sorkin and Carpenter, 1993), weLigand-Induced NKG2D Modulation
investigated whether this would affect NKG2D modula-To further elucidate the mechanism of NKG2D modula-
tion. As shown Figure 4D, NKG2D modulation was inhib-tion, we established an in vitro model using transfectants
ited in hypertonic medium (0.45 M sucrose), suggestingof Ba/F3-expressing mouse NKG2D and DAP10. Ba/F3
that clathrin-dependent endocytosis may be involved inis a transformed pro-B cell line lacking NK cell function.
NKG2D modulation.This permits analysis of interactions of NKG2D with li-
Further studies were conducted to determine whethergand in the absence of target cell killing or other po-
signaling is required for efficient ligand-induced modu-tential pathways involved in NK cell activation.
lation of NKG2D. DAP10 possesses a YxxM motif, whichNKG2DDAP10-Ba/F3 cells were cocultured with
binds to the p85 subunit of PI3 kinase and Grb-2 (ChangRAE-1 transfected RMA (RMA-RAE-1) cells or mock-
et al., 1999; Wu et al., 1999). In addition, it is possibletransfected RMA cells. After 24 hr, NKG2D expression
that the clathrin adaptor complex AP-1 and/or AP-2 willon the Ba/F3 transfectants was modulated by coculture
bind the YxxM motif (Brodsky et al., 2001). We examinedwith RAE-1 transfected RMA cells, but not mock-trans-
whether the YxxM motif of DAP10 binds to AP-2 clathrinfected RMA cells (Figure 4A). To exclude the possibility
adaptor complexes. However, we could not detect AP-2that NKG2D was masked by the presence of RAE-1
association with DAP10 (data not shown). These find-protein that was shed from the RAE-1 transfectants,
ings prompted us to examine whether PI3 kinase activityrather than due to ligand-induced receptor modulation,
is involved in NKG2D modulation. To this end, NKG2D-the NKG2DDAP10-Ba/F3 cells cocultured with RAE-
DAP10 Ba/F3 transfectants were cocultured with RAE-11 RMA were washed briefly in acidic buffer (pH 4.0)
transfectants in the presence of the PI3 kinase inhibitor,before staining with anti-NKG2D mAb. While washing
LY294002. In the presence of the PI3 kinase inhibitor,with acidic buffer completely removed soluble NKG2D
substantially less modulation of NKG2D was observed,ligand (i.e., an H-60-Ig fusion protein [Cerwenka et al.,
compared to the amount of ligand-induced receptor2000]) from NKG2DDAP10-Ba/F3 transfectants (data
modulation that was induced in the absence of the drugnot shown), this treatment did not reveal expression of
(Figure 4E). To further confirm the participation of DAP10NKG2D on the cells cocultured overnight with RAE-1
in receptor modulation, we generated Ba/F3 transfec-RMA cells (Figure 4A). Furthermore, the DAP10 protein
tants expressing NKG2D and a DAP 10 protein with aexpressed in the NKG2D transfectants had an N-ter-
Y-F mutation in the YxxM motif (DAP10 Y-F mut-Ba/F3).minal Flag epitope tag that also demonstrated downreg-
The NKG2D mutant DAP10 complex was expressed atulation after ligand-induced modulation of NKG2D (data
a similar level as wild-type NKG2D-DAP10 in the Ba/F3not shown). Together, these results indicated that the
transfectants. Ligand-induced modulation of NKG2Dobserved decreased levels of NKG2D were due to recep-
was remarkably less efficient in transfectants express-tor modulation, rather than masking by soluble ligand.
ing the mutant DAP10 compared with wild-type DAP10To determine whether NKG2D was internalized after
(Figure 4F), suggesting that DAP10-mediated signalbinding RAE-1, the NKG2D-bearing cells after coculture
transduction is involved. However, partial NKG2D modu-with RAE-1 transfectants were fixed, permeabilized, and
lation was observed in the DAP10 mutant transfectant,analyzed for the presence of intracytoplasmic NKG2D.
similar to results obtained using the PI3 kinase inhibitor.While the amount of NKG2D on the cell surface was
reduced on cells cocultured with RAE-1 transfectants,
no difference was observed in the total amount of Discussion
NKG2D detected by staining of permeabilized cells,
which permits detection of both surface and cyto- In this study, we established that the impaired functions
of NK cells in NOD mice are at least in part caused byplasmic antigen (Figure 4B). Therefore, modulation of
NKG2D may be caused by internalization. To determine NKG2D modulation on activated NK cells. Diminished
NKG2D on activated NOD NK cells was secondary towhether degradation in lysosomes is involved in NKG2D
thick line shows NKG2D ligand expression on NK cells.
(D) NKG2D ligand transcripts in C57BL/6, NK1.1 NOD, and NOD NK cells. Real-time PCR was performed as in (B). Data were normalized to
the amount of HPRT mRNA. N.D., not detected.
(E) Expression of RAE-1 on NK1.1 NOD and NOD NK cells. NK cells were prepared as in (A). NK cells were stained with biotinylated anti-
RAE-1 mAb (CX1) or biotinylated isotype cIg and then stained with PE-conjugated streptavidin. The dotted line shows isotype cIg staining,
and the thick line shows RAE-1 expression on NK cells. These results were reproducible (three independent experiments), and representative
data are shown. Anti-RAE-1 mAb CX1 predominantly reacts with RAE-1 but also reacts weakly with RAE-1 and RAE-1 but not H-60.
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Figure 3. Ligand-Induced NKG2D Modulation
(A) Modulation of NKG2D on NK cells by coculture with ligand-bearing cells. NK cells were prepared from C57BL/6 mice and cocultured with
mock-transfected B16 melanoma cells or RAE-1 transfected B16 cells in the presence of IL-2 (500 U/ml). After 48 hr culture, NK cells were
costained with anti-NK1.1 mAb and anti-NKG2D mAb. The dotted line shows cIg staining, and the thick line shows NKG2D expression on
NK1.1 NK cells (upper panel). The lower panel shows CD44 expression on these NK cells (thick line).
(B) Cytotoxicity against YAC-1 was decreased in NK cells cocultured with RAE-1 B16 transfectants. NK cells were cocultured with RAE-1
B16 or mock B16 transfectants as in Figure 3A.
(C) NKG2D-dependent cytotoxicity was decreased in NK cells cocultured with RAE-1 B16 transfectants. NK cells were cocultured with RAE
1 B16 (filled circles) and mock B16 transfectants (open circles) as in Figure 3A. Cytotoxic activity against RAE-1-bearing Ba/F3 cells (Ba/
F3 RAE-1) or mock transfectants (Ba/F3 mock) was tested by using a 4 hr 51Cr release assay. Data are represented as the mean % cytotoxicity	
SD (triplicates). Similar results were obtained in two independent experiments.
(D) IFN- production induced by crosslinking with anti-NKG2D mAb was reduced in NK cells previously cocultured with RAE-1 B16 transfec-
tants. NK cells cocultured with mock or RAE-1 B16 transfectants were harvested, purified from the residual tumor cells, and then stimulated
with immobilized mAb (3 
g ml1) for 18 hr. Culture supernatants were collected for measurement of IFN- by ELISA. IFN- was induced by
culturing NK cells in plates coated with control rat IgG (open column), anti-NKG2D mAb (filled column), or anti-NK1.1 mAb (hatched column).
As a positive control for cytokine production, NK cells were cultured with IL-12 (gray column). Data are represented as the mean ng ml1 	
SD (triplicates). Differences in IFN- production of NK cells cocultured with B16 or RAE-1 B16 induced by anti-NKG2D mAb stimulation were
highly significant. p  0.01, NKB16 mock versus NKB16 RAE-1.
(E) NKG2D was modulated in vivo on NK cells in mice bearing a RAE-1 tumor. RAE-1 RMA (1  107 ) or mock-transfected RMA cells (1 
NKG2D in NOD Mice
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ligand-induced internalization of the receptor. Further are induced in NK cells by activation, whereas in
C57BL/6 they are not. Similarly, the ligands of NKG2D instudies determined that activation of PI3 kinase through
the YxxM motif of DAP10 is involved in this process. In humans (i.e., MICA, MICB, and ULBP) are polymorphic,
whereas DAP10 and NKG2D in mice and humans arethis regard, modulation of NKG2D on NK cells and CD28
on T cells is similar (Cefai et al., 1998) but distinct from monomorphic. It will be of interest to determine whether
NKG2D expression and function in human NK cells isCTLA-4 modulation (Schneider et al., 1999). While ex-
pression of CTLA-4 is regulated by AP-2 binding, we influenced by the induction of NKG2D ligands on NK
cells in certain individuals. NKG2D-dependent cytotox-could not detect AP-2 binding to phosphorylated or non-
phosphorylated DAP10, similar to what was reported icity was also reduced in fresh NOD NK cells as com-
pared with C57BL/6 NK cells (data not shown). However,previously for CD28 (Schneider et al., 1999). However,
modulation of NKG2D was inhibited in hypertonic me- the expression levels of NKG2D in fresh NOD and
NK1.1NOD NK cells were similar to fresh C57BL/6 NKdium, suggesting that endocytosis of NKG2D may utilize
a clathrin coated-pit dependent pathway, similar to cells (data not shown). As reported previously, the NK
cell abnormalities in NOD mice and IDDM patients mayCD28 (Schneider et al., 1999) and epidermal growth fac-
tor receptor (Sorkin and Carpenter, 1993). be due to multiple defects (Attallah et al., 1987; Poulton
et al., 2001; Shultz et al., 1995). Therefore, NK cell de-A striking difference between NK cells from C57BL/6
and NOD mice was the finding that NK cell activation fects other than NKG2D modulation may be present in
NOD mice.induced the RAE-1 ligands of NKG2D in NOD but not
C57BL/6 NK cells. Thus, in NOD mice both the NKG2D We found that the interaction of RAE-1 and NKG2D
on NK cells induced dysfunction of activated NK cells.receptor and its ligands are expressed on the same
NK cell, which may cause self-modulation of NKG2D In the case of NOD NK cells, this could be caused by
modulation of NKG2D by ligand expression within theexpression and function. The difference between NK
cells in NOD and C57BL/6 appears to be determined at cytoplasm of the NK cells themselves because NOD NK
cells express both receptor and ligands. Interactionsthe level of expression of RAE-1 and not the NKG2D
receptor. Indeed, the nucleotide sequences of coding between C57BL/6 NK cells, which do not express
NKG2D ligands, and tumors expressing RAE-1 resultedregions of NKG2D and DAP10 are identical in NOD and
C57BL/6 mice (our unpublished data), and we show that in modulation of receptor expression and function. This
was demonstrated in vitro but also was observed onthese genes were transcribed in equal amounts in NOD
and C57BL/6 NK cells. Furthermore, activated NK cells NK cells isolated from the spleen (but not the liver) of
mice that received an intrasplenic injection of a lym-from NK1.1 congenic NOD mice, which have both the
NK1.1 allele and the linked NKG2D locus from C57BL/6, phoma transfected with RAE-1. These data indicated
that NKG2D on NK cells was modulated by the interac-demonstrated diminished NKG2D expression and func-
tion. It should be noted that the RAE-1 genes are not tion with RAE-1 in vivo in the local microenvironment.
Initial interactions between NK cells and NKG2D ligand-linked to NK1.1; therefore, the RAE-1 genes are of NOD
origin in the NK1.1 NOD congenic mice. When C57BL/6 bearing cells may trigger killing and cytokine production.
However, prolonged exposure to ligands may desensi-NK cells were cocultured with transfectants expressing
RAE-1, NKG2D on the NK cells was modulated and tize NK cells rendering them functionally anergic. This
has implications in the context of tumor developmentNKG2D-dependent functions were impaired to an extent
comparable to activated NOD NK cells. This phenotype because secretion of soluble NKG2D ligands by tumors
(Groh et al., 2002) or prolonged exposure of NK cells towas reversible, since NKG2D expression and function
recovered when C57BL/6 NK cells were further cultured ligand-bearing tumors may render them dysfunctional.
This may contribute to tumor escape from NK cell andin the absence of ligand-bearing cells. Consistent with
our study, previous reports have demonstrated that NK CD8 T cell immune surveillance.
NKG2D may also play a role in autoimmunity. If NKG2Dcell cytotoxicity was decreased following exposure to
target cells, and the cytolytic activity was recovered ligands are induced due to inflammation or perhaps
inappropriately overexpressed in autoimmune-predis-following culture in the presence of activating cytokines
(Abrams and Brahmi, 1988; Jewett and Bonavida, 1995; posed individuals, this may exacerbate the disease. In
the case of IDDM, perhaps overexpression of NKG2DPerussia and Trinchieri, 1981; Timonen et al., 1979). It
is noteworthy that the NKG2D ligands are remarkably ligands in the pancreas of certain predisposed individu-
als may costimulate autoreactive CD8 T cells, therebydifferent in C57BL/6 and NOD mice. NOD mice express
RAE-1, , and  and H-60, whereas C57BL/6 mice inducing or augmenting the disease. In preliminary stud-
ies, we have detected transcription of RAE-1 genes inlack these ligands but instead express RAE-1 and -
(Cerwenka and Lanier, 2001). As yet, little is known about the pancreas of diseased NOD mice but not young,
healthy mice. Of particular interest is the remarkablethe transcriptional regulation of RAE-1 gene expression,
but our findings suggest that the RAE-1 genes in NOD polymorphism of the genes encoding the NKG2D li-
107 ) were injected directly into the spleen of C57BL/6 mice. After 5 days, splenic NK cells were harvested and NKG2D expression was
analyzed.
(F) Recovery of NKG2D expression in the absence of ligand. C57BL/6 NK cells were cocultured with irradiated RAE-1 transfected B16 or
mock-transfected B16 cells. After 24 hr, modulation of NKG2D was confirmed on cells cocultured with ligand-bearing tumor cells. NK cells
were harvested, cultured in IL-2 only for 1 day, and then stained with anti-NK1.1 mAb and anti-NKG2D mAb. The dotted line shows cIg
staining, and the thick line shows NKG2D expression on NK1.1 NK cells.
Immunity
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Figure 4. Modulation of NKG2D Is Regulated by the YxxM Motif of DAP10
(A) Ba/F3 cells transfected with NKG2D and DAP10 (Ba/F3 NKG2D-DAP10) were cocultured with RMA mock transfectants or RMA cells
transfected with RAE-1. The NKG2D-DAP10 Ba/F3 transfectants also expressed GFP as a result of transduction with an IRES-GFP retroviral
vector. After coculture and prior to staining with anti-NKG2D mAb or H-60-Ig fusion protein, cells were washed briefly in an acidic buffer
(RPMI 1640 adjusted to pH 4.0 with HCl with 3% FCS). This was done to elute any shed RAE-1 from the NKG2D transfectant, which may
prevent detection of NKG2D because of masking by ligand. As a positive control, we demonstrated that this acid treatment successfully
removed H-60-Ig Fc fusion protein from Ba/F3 NKG2D-DAP10 cells (data not shown).
(B) Detection of intracellular NKG2D after modulation. Ba/F3 NKG2D-DAP10 cells were cocultured with RMA or RMA RAE-1 cells for 14 hr.
After coculture, cells were fixed in 1% paraformaldehyde and permeabilized by saponin. Then, these cells were stained with a-NKG2D mAb.
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with the immobilized antibodies, as described previously (Ogasa-gands in mice and humans (e.g., more than 50 alleles
wara et al., 2002). To block Fc receptor-dependent activation, NKof human MICA have been identified). Polymorphisms
cells were pretreated with soluble anti-CD16/32 mAb 2.4G2 (BDof human MICA have been associated with a variety of
PharMingen, San Diego, CA) (10 
g/ml) for 30 min. The amount of
autoimmune disorders, including type I diabetes, ulcera- IFN- in the culture supernatants was determined with a mouse
tive colitis, primary sclerosing cholangitis, familial Medi- IFN--specific ELISA kit (OptEIA mouse IFN- set), purchased from
terranean fever, and Behcet’s disease (Mizuki et al., BD PharMingen (San Diego, CA) and used according to the manufac-
turer’s instructions. Statistical analysis was performed using a two-1997; Norris et al., 2001; Sugimura et al., 2001; Touitou
sample Student’s t test.et al., 2001; Wallace et al., 1999). Whether expression
of NKG2D ligands is involved in the induction of disease
or only results as a consequence of inflammation is
Cell Lines, Plasmids, and Transfectants
unknown. Nonetheless, our findings suggest that the For sequence analysis, mouse DAP10 and NKG2D were amplified
NKG2D pathway should be considered in autoimmune from cDNA prepared from NOD NK cells by RT-PCR using oligonu-
disease, as well as cancer. cleotide primers (DAP10 sense primer ATG GAC CCC CCA GGC
TAC CTC, DAP10 antisense primer TCA GCC TCT GCC AGG CAT
Experimental Procedures GTT, NKG2D sense primer GAA ACA GGA TCT CCC TTC, and
NKG2D antisense primer CCG AGA CAA TTC TCT TG). PCR prod-
Mice ucts were sequenced using standard methods. The Ba/F3 pro-B
Six- to eight-week-old C57BL/6 mice were purchased from Charles cell line was kindly provided by Dr. T. Kitamura (Univ. of Tokyo),
River (Wilmington, MA). NOD mice were obtained from Taconic (Ger- and the RMA T leukemia cell line was kindly provided by Dr. J. Ryan
mantown, NY). NK1.1-congenic NOD mice were generated as de- (UCSF). The B16 melanoma cell line was generously provided by
scribed previously (Carnaud et al., 2001). Experiments were per- Dr. J. Allison (UC-Berkeley). These cells were cultured in RPMI 1640
formed using gender- and age-matched mice. All mice were medium containing 10% FCS, 5  105 M 2-mercaptoethanol, and
maintained under specific pathogen-free conditions in the animal 2 mM glutamine. Since Ba/F3 cells are IL-3 dependent for their
facility of the University of California, San Francisco (UCSF). All proliferation, the Ba/F3 cells were transfected with a mouse IL-3-
experiments were performed according to the guidelines of the cDNA plasmid to provide for autocrine growth (kindly provided by
UCSF Committee on Animal Research.
Dr. S. Tangye [Sydney, Australia]). All transfectants (Ba/F3 NKG2D
DAP10, Ba/F3 NKG2D  mutant DAP10 Y-F, Ba/F3 mock, Ba/F3
Reagents, Cytokines, and Antibodies
RAE-1, B16 mock, B16 RAE-1, RMA mock, and RMA RAE-1)
Human recombinant IL-2 was generously provided by the NCI BRB
were established by retroviral transduction (Kinsella and Nolan,
Preclinical Repository. Mouse recombinant IL-12 was kindly pro-
1996; Onihsi et al., 1996). RMA cells were transduced by usingvided by Dr. J.P. Houchins (R&D Systems, Minneapolis, MN). The
retroviruses generated with the pMX-puro vector (Kinsella and No-PI3 kinase inhibitor, LY294002 was purchased from CALBIOCHEM
lan, 1996; Onihsi et al., 1996). Other stable transfectants were estab-(La Jolla, CA). Anti-mouse NKG2D monoclonal antibody CX5 (rat
lished using retroviruses generated with the pMX-pie vector. TheIgG2a isotype) was generated by immunizing rats with purified pro-
murine NKG2D cDNA was cloned by PCR using oligonucleotidetein of mouse NKG2D kindly provided by Dr. Chris O’Callaghan
primers (sense 5-GAGCAAATGCCATAATTACGACC -3, antisense(CIT). The antibody recognizes the NKG2D extracellular domain and
5-ACCGCCCTTTTCATGCAGATG-3), and the cDNA was ligatedefficiently blocks the binding of NKG2D to its ligands. Anti-mouse
into the pMX-pie vector. The Y residue in the cytoplasmic domainRAE-1 monoclonal antibody CX1 (rat IgG2b isotype) was generated
of Flag-human DAP10 (Wu et al., 2000) was mutated to F by standardby immunizing rats with CHO cells stably transfected with mouse
PCR mutagenesis, and these cDNA were ligated into pMX-neo vec-RAE-1. CX1 mAb binds strongly to RAE-1 and weakly to RAE-1
tors. This construct was transfected into Phoenix-A packaging cellsand RAE-1, but does not react with RAE-1 or RAE-1. Binding of
(generously provided by Dr. Garry Nolan, Stanford, CA) by usingRAE-1 to NKG2D is blocked in the presence of CX1 mAb.
Lipofectamine 2000 (Gibco BRL) (Kinsella and Nolan, 1996; Onihsi
et al., 1996). Two days later, the supernatants containing virusesCytokine Production
were collected and used to infect 5  104 Ba/F3 and RMA cells inNK cells (2  105 ) were placed in RPMI-1640 containing 10% FCS
and IL-2 (2000 U/ml) and were cultured for 18 hr in plates precoated the presence of polybrene (8 
g/ml).
(Note that the staining intensity of anti-NKG2D mAb was less on fixed cells, compared with fresh cells, probably because fixation affected
the antigen.)
(C) NKG2D modulation was not influenced by lysosome inhibitors. Ba/F3 NKG2D-DAP10 cells were cocultured with RMA cells or RMA RAE-1
in the presence or absence of lysosome inhibitors, NH4Cl (50 mM) or chloroquine (100 
M) for 6 hr. Data using NH4Cl (50 mM) are shown.
Similar results were obtained using the lysosome inhibitor, chloroquine (100 
M).
(D) Clathrin-dependent endocytosis is involved in NKG2D downmodulation. Ba/F3 NKG2D-DAP10 cells were cocultured with RMA or RMA
RAE-1 cells in the presence or absence of medium containing 0.45 M sucrose. The percentage reduction of NKG2D surface expression in
the presence of ligand was calculated as follows: % of NKG2D surface expression  mean fluorescence of Ba/F3 NKG2D-DAP10 cells
cocultured with RMA RAE-1  100/mean fluorescence of Ba/F3 NKG2D-DAP10 cells cocultured with RMA.
(E) PI3 kinase was involved in NKG2D modulation. Ba/F3 NKG2D-DAP10 cells were cocultured with RMA or RMA RAE-1 cells for 14 hr in
the presence of PI3 kinase inhibitor, LY294002 (30 
M). The dotted line shows cIg staining. The gray histogram shows NKG2D expression on
Ba/F3 NKG2D-DAP10 cells cocultured with RMA RAE-1 cells in the presence of DMSO (mean  15.1) or LY294002 (mean  38.2), and the
thick line shows NKG2D expression on Ba/F3 NKG2D-DAP10 cells cocultured with RMA mock transfectants in the presence of DMSO (mean 
63.9) or LY294002 (mean  66.2).
(F) The YxxM motif of DAP10 regulates NKG2D modulation. Ba/F3 NKG2D-DAP10 cells or Ba/F3 NKG2D mutant DAP10 Y-F cells were
cocultured with RMA or RMA RAE-1 cells for 14 hr. The dotted line shows cIg staining. The gray histogram shows NKG2D expression on
Ba/F3 NKG2D-DAP10 cells (upper panel) or Ba/F3 NKG2D-DAP10 (Y-F) mutants (lower panel) cocultured with RMA RAE-1. The thick lines
show NKG2D expression on Ba/F3 NKG2D-DAP10 cells (upper panel) or Ba/F3 NKG2D-DAP10 (Y-F) mutants (lower panel) cocultured with
RMA. Mean fluorescence is as follows: NKG2D expression on Ba/F3 NKG2D-DAP10 cells cocultured with RMA (mean  148.64), Ba/F3
NKG2D-DAP10 cells cocultured with RMA RAE-1 (mean  35.42), NKG2D expression on Ba/F3 NKG2D-DAP10 (Y-F) cells cocultured with
RMA (mean  110.89), Ba/F3 NKG2D-DAP10 cells cocultured with RMA RAE-1 (mean  71.5), These results were reproducible (two
independent experiments), and representative data are shown.
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Preparation of NK Cells TCT GCT-TAMRA (H60), and FAM-CAA ACT TTG CTT TCC CTG
GTT AAG CAG TAC AGC-TAMRA (HPRT). PCR primers were asNK cells were prepared as described previously (Ogasawara et al.,
2002). In brief, spleen cells were incubated with anti-CD4 mAb (clone follows: RAE-1; sense GTGAAACGATTGAAATTCTTGATACC, anti-
sense GCTTTT CCTTGGGCTGCTTT, RAE-1; sense AAGTAACAGK1.5) and anti-CD8 mAb (clone 53-6.7), and thereafter these cells
were mixed with magnetic beads coated with goat anti-mouse im- TAAACAAGACCATGACTTCAG, antisense TCCTCAACTTCTGGCA
CAAATTT, RAE-1 ; sense GACGGCAAATGCCACT GAA, antisensemunoglobulin (Ig) Ab and goat anti-rat Ig Ab (Advanced Magnetic,
Inc., Cambridge, MA). CD4, CD8, and surface Ig (sIg) positive cells CCACTTTGGTGTTAGACACCTTGTC, RAE-1; sense CAACTTGAC
CATCAAGGCTCCTA, antisense GATAAGTATTTCACCCACGAAGCA,were removed by magnetic cell sorting. The CD4-, CD8- and Ig-
depleted splenocytes were stained with a PE-conjugated pan-NK RAE-1 ; sense CAGGTGACCCAGGGAAGATG, antisense CTCAACT
CCTGGCACAAATCG, DAP10; sense GCGGTCATGTCACTCCTAcell mAb DX5 (BD PharMingen, San Diego, CA), followed by incuba-
tion with magnetic microbeads coated with anti-PE Ab (Miltenyi ATTG, antisense ACCATCTTCTTGGG CAGGC, NKG2D; sense
CGATTCACCCTTAACACATTGATG, antisense GGGACTT CCTTGBiotec Inc., Germany). Thereafter, DX5 cells were isolated by mag-
netic cell sorting using a MACS (Miltenyi Biotec Inc., Germany). The TTGCACAATAC, HPRT; sense TGG AAA GAA TGT CTT GAT TGT
TGA A, antisense AGC TTG CAA CCT TAA CCA TTT TG, H60; sensepurity of the DX5 cells was more than 95%, as determined by flow
cytometric analysis. The yield of purified NK cells per spleen from GAG CCA CCA GCA AGA GCA A, antisense CCA GTA TGG TCC
CCA GAT AGC T. Total RNA was treated with DNase I, and thenthe different mouse strains was as follows: C57BL/6 (number 
106  1.36 	 0.13), NK1.1 NOD (number  105  8.17 	 0.23), first-strand cDNA was synthesized by using random hexamer prim-
ers. The cycling conditions for real-time PCR were: 50C for 10 min,NOD (number  105  6.14 	 0.15). The purified NK cells were
cultured in RPMI-1640 supplemented with 10% FCS and 5 105 M followed by 45 cycles of 95C for 30 s, and 60C for 2 min. Data
were analyzed using the Sequence Detector v1.7 Analysis Software2-mercaptoethanol in the presence of 4000 U/ml human recombi-
nant IL-2 for 3–5 days. (Applied Biosystems).
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